The distinct roles of sialyltransferases in cancer biology and onco-immunology

M Hugonnet, P Singh, Q Haas… - Frontiers in …, 2021 - frontiersin.org
Aberrant glycosylation is a key feature of malignant transformation. Hypersialylation, the
enhanced expression of sialic acid-terminated glycoconjugates on the cell surface, has …

Aberrant sialylation in cancer: biomarker and potential target for therapeutic intervention?

S Pietrobono, B Stecca - Cancers, 2021 - mdpi.com
Simple Summary Sialylation is a post-translational modification that consists in the addition
of sialic acid to growing glycan chains on glycoproteins and glycolipids. Aberrant sialylation …

LncRNA PICSAR promotes cell proliferation, migration and invasion of fibroblast-like synoviocytes by sponging miRNA-4701-5p in rheumatoid arthritis

X Bi, XH Guo, BY Mo, ML Wang, XQ Luo, YX Chen… - …, 2019 - thelancet.com
Abstract Background Long non-coding RNAs (lncRNAs) have drawn increasing attention
because they play a pivotal role in various types of autoimmune diseases, including …

Sialyltransferase ST3GAL1 promotes cell migration, invasion, and TGF-β1-induced EMT and confers paclitaxel resistance in ovarian cancer

X Wu, J Zhao, Y Ruan, L Sun, C Xu, H Jiang - Cell death & disease, 2018 - nature.com
Sialyltransferases transfer sialic acid to nascent oligosaccharides and are upregulated in
cancer. The inhibition of sialyltransferases is emerging as a potential strategy to prevent …

Resistance to cisplatin in human lung adenocarcinoma cells: Effects on the glycophenotype and epithelial to mesenchymal transition markers

LM da Fonseca, VA da Silva, KM da Costa… - Glycoconjugate …, 2022 - Springer
The characteristics that grant the most malignancy to cancer cells are the ability to evade
apoptotic mechanisms and the capacity to migrate beyond the boundaries of the original …

Non-coding RNAs in leukemia drug resistance: new perspectives on molecular mechanisms and signaling pathways

A Rahmati, A Mafi, O Vakili, F Soleymani, Z Alishahi… - Annals of …, 2024 - Springer
Like almost all cancer types, timely diagnosis is needed for leukemias to be effectively
cured. Drug efflux, attenuated drug uptake, altered drug metabolism, and epigenetic …

Epigenetic bases of aberrant glycosylation in cancer

F Dall'Olio, M Trinchera - International journal of molecular sciences, 2017 - mdpi.com
In this review, the sugar portions of glycoproteins, glycolipids, and glycosaminoglycans
constitute the glycome, and the genes involved in their biosynthesis, degradation, transport …

The expression and functional analysis of the sialyl-T antigen in prostate cancer

R Bai, X Luan, Y Zhang, C Robbe-Masselot… - Glycoconjugate …, 2020 - Springer
Aberrant glycosylation is a featured characteristic of cancer and plays a role in cancer
pathology; thus an understanding of the compositions and functions of glycans is critical for …

Sialyltransferases and neuraminidases: potential targets for cancer treatment

S Nag, A Mandal, A Joshi, N Jain, RS Srivastava… - Diseases, 2022 - mdpi.com
Cancers are the leading cause of death, causing around 10 million deaths annually by
2020. The most common cancers are those affecting the breast, lungs, colon, and rectum …

The lncRNA MEG3 mediates renal cell cancer progression by regulating ST3Gal1 transcription and EGFR sialylation

A Gong, X Zhao, Y Pan, Y Qi, S Li… - Journal of cell …, 2020 - journals.biologists.com
Long noncoding RNAs (lncRNAs) have emerged as important regulators of cancer
progression. Abnormal sialylation leads to renal cell carcinoma (RCC) malignancy …